It would also be interesting to explore the effects of these phytocannabinoids in other disease models in which T-type channels and GPR55 play a role, such as in models of insomnia, pain, and gastrointestinal disorders (Harding and Zamponi, 2022). This evidence concerns the gene GPR55 and digestive system disorder.